Lexeo Therapeutics
LXEO
LXEO
90 hedge funds and large institutions have $170M invested in Lexeo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
+2
Holders Change %
+2.27%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
36
Reduced
17
Closed
15
Calls
$8K
Puts
$8K
Net Calls
–
Net Calls Change
-$24K
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.1M |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$13.9M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$8.48M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$8.41M |
| 5 |
Millennium Management
New York
|
+$7.09M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CC
101
Corton Capital
Carrying Place,
Ontario, Canada
| – | -$44.1K | -12,711 | Closed |
|
|
CF
102
Corebridge Financial
Houston,
Texas
| – | -$40.1K | -11,544 | Closed |
|
|
AI
103
Allostery Investments
Stamford,
Connecticut
| – | -$17.5K | -5,054 | Closed |
|
104
Comerica Bank
Dallas,
Texas
| – | -$6.11K | -1,761 | Closed |
|
|
CCM
105
Coldstream Capital Management
Bellevue,
Washington
| – | -$323 | -93 | Closed |
|